SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-17-040539
Filing Date
2017-11-01
Accepted
2017-11-01 17:02:21
Documents
48
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q form10q.htm 10-Q 523744
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 13070
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 13417
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 5880
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 6271
  Complete submission text file 0001140361-17-040539.txt   3236939

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT edge-20170930.xml EX-101.INS 470451
7 XBRL TAXONOMY EXTENSION SCHEMA edge-20170930.xsd EX-101.SCH 32195
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edge-20170930_cal.xml EX-101.CAL 36826
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edge-20170930_def.xml EX-101.DEF 142288
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE edge-20170930_lab.xml EX-101.LAB 529882
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edge-20170930_pre.xml EX-101.PRE 260498
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37568 | Film No.: 171169743
SIC: 2834 Pharmaceutical Preparations